Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pat LoRusso

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Angiogenesis pathway inhibitorsRoy S Herbst, Pat LoRusso, Takeshi Isobe, et al.
Clinical Pharmacokinetics|December 21, 2016
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic FunctionChunze Li, Priya Agarwal, Ekaterina Gibiansky, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Angiogenesis pathway inhibitorsRoy S Herbst, Pat LoRusso, Takeshi Isobe, et al.
Clinical Pharmacokinetics|December 21, 2016
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic FunctionChunze Li, Priya Agarwal, Ekaterina Gibiansky, et al.
Pageof 1